DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

Issue 05 · Volume 47 · July 2021 DOI: 10.1055/s-011-51252 Altered Fibrinolysis: Clinical Impact and Diagnostic Challenges Guest Editors: Anne-Mette Hvas, MD, PhD, Julie Brogaard Larsen, MD, PhD, and Ton Lisman, MSc, PhD

Editorial

  • 467
  • Preface

  • 477
    Larsen, Julie Brogaard; Lisman, Ton; Hvas, Anne-Mette:

    Preface: Altered Fibrinolysis—Clinical Impact and Diagnostic Challenges

  • Review Article

  • 480
  • 490
    Kietsiriroje, Noppadol; Ariëns, Robert A.S.; Ajjan, Ramzi A.:

    Fibrinolysis in Acute and Chronic Cardiovascular Disease

  • 506
  • 512
    Colomina, Maria J.; Méndez, Esther; Sabate, Antoni:

    Altered Fibrinolysis during and after Surgery

  • 520
    Roberts, Ian; Brenner, Amy; Shakur-Still, Haleema:

    Tranexamic Acid Treatment for Trauma Victims

  • 527
  • 538
    Hovgesen, Nadia Thrane; Larsen, Julie Brogaard; Fenger-Eriksen, Christian; Hansen, Anne Kirkeby; Hvas, Anne-Mette:

    Efficacy and Safety of Antifibrinolytic Drugs in Pediatric Surgery: A Systematic Review

  • 569
    Bønløkke, Søren Thorgaard; Ommen, Hans Beier; Hvas, Anne-Mette:

    Altered Fibrinolysis in Hematological Malignances

  • 581
    Winther-Larsen, Anne; Sandfeld-Paulsen, Birgitte; Hvas, Anne-Mette:

    Hyperfibrinolysis in Patients with Solid Malignant Neoplasms: A Systematic Review

  • 589
  • 601
    von Meijenfeldt, Fien A.; Lisman, Ton:

    Fibrinolysis in Patients with Liver Disease

  • 610